Clinical Trials Browser

Phase 1 × Active not recruiting × balstilimab × Clear all

Pancreatic Cancer Metastatic

NCT03860272 2025-02-06

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

GastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fibrolamellar hepatocellular carcinoma, Carcinoma, Non-Small-Cell Lung, Hemangiosarcoma, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Clinical Trials

The Seven Trial: Exploiting the Unfolded Protein Response

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer